Dr Clarence Mast, MD in Meshoppen, PA - Family Medicine

Dr Clarence Mast, MD is a Family Medicine physician based in Meshoppen, Pennsylvania. Dr Clarence Mast is licensed to practice in Pennsylvania (license number MD 0126030E) and his current practice location is Route 6, Meshoppen, Pennsylvania. He can be reached at his office (for appointments etc.) via phone at (570) 833-8300.

NPI number for Dr Clarence Mast is 1902898638 and his current mailing address is Rr 1 Box 3j, Hospital Dr, Towanda, Pennsylvania. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1902898638.

Contact Information

	Dr Clarence Mast, MD
	Route 6, Meshoppen, PA 18630
	(570) 833-8300
	(570) 833-8310

Physician's Profile

Full Name	Dr Clarence Mast
Gender	Male
Speciality	Family Medicine
Location	Route 6, Meshoppen, Pennsylvania
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1902898638
Provider Enumeration Date: 08/18/2005
Last Update Date: 03/08/2010

Medical Identifiers

Medical identifiers for Dr Clarence Mast such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1902898638	NPI	-	NPPES
677564	Medicaid	PA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	MD 0126030E (Pennsylvania)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Clarence Mast is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Clarence Mast, MD Rr 1 Box 3j, Hospital Dr, Towanda, PA 18848-9706 Ph: (570) 265-6300	Dr Clarence Mast, MD Route 6, Meshoppen, PA 18630 Ph: (570) 833-8300

News Archive

BioRx added to Zemaira distribution network

BioRx, a national specialty pharmacy and infusion services provider, has been added to the limited distribution network for Zemaira [alpha-1 proteinase inhibitor (human)]. Zemaira is indicated for chronic augmentation and maintenance therapy in individuals with alpha1-antitrypsin (AAT) deficiency and clinical evidence of emphysema.

Eggs for breakfast associated with greater satiety and reduced calorie consumption

New research presented at the 19th European Congress on Obesity in Lyon, France reports that eating eggs for breakfast is associated with greater satiety and reduced calorie consumption at lunch than eating wheat-based breakfast foods like ready-to-eat breakfast cereal. Participants in the study reported feeling fuller following the egg breakfast and tests of their hunger hormone levels supported their self-reported observations.

Texas Children's Fetal Center announces 200th TTTS laser ablation surgery milestone

As one of the leading medical centers in the U.S. diagnosing and treating twin-to-twin transfusion syndrome (TTTS), Texas Children's Fetal Center is proud to announce the successful completion of its 200th TTTS laser ablation surgery.

NYBC, UC Davis Health System partner to manufacture potential stem cell therapies

New York Blood Center today announced a new collaboration with the University of California, Davis, Health System to manufacture specialized lines of stem cells as potential therapies for repair and regeneration of retina, kidney, lung and liver tissue, as well as for the treatment of neurodegenerative disorders such as Parkinson's, Alzheimer's and Huntington's disease.

Dr Clarence Mast, MD - Family Medicine in Meshoppen, PA